Mannkind MNKD
NASDAQ MNKD
$3.08 -0.02 (-0.65%)
As of: Oct 21, 2026 · 12:53 PM EDT

Mannkind (MNKD) Construction in Progress (2021 - 2022)

Updated

Mannkind (MNKD) reported Construction in Progress of $7.7 million for Q1 2022, up 63.8% from the prior quarter.

Analysis

Mannkind (MNKD) Construction in Progress (2021 - 2022) Analysis & Trends

At the end of FY2021, Mannkind posted Construction in Progress of $4.7 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Construction in Progress (Qtr)
1 Eli Lilly 1,133.15 Bn 1,101.73 Bn 19.71 Bn -
2 Johnson & Johnson 616.41 Bn 534.94 Bn 17.26 Bn -
3 AbbVie 501.01 Bn 474.12 Bn 12.70 Bn -
4 Merck 367.15 Bn 321.53 Bn 12.21 Bn -
5 Novartis Ag 298.00 Bn 261.99 Bn 11.24 Bn -
6 Astrazeneca 261.56 Bn 235.25 Bn 12.86 Bn -
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn -
8 Gilead Sciences 190.38 Bn 164.57 Bn 6.22 Bn -
9 Pfizer 169.76 Bn 116.40 Bn 10.94 Bn -
10 Mannkind 952.31 Mn 272.95 Mn 94.97 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 7.70 Mn
Dec 31, 2021 4.70 Mn
Sep 30, 2021 1.60 Mn
API Access

Mannkind Construction in Progress API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=construction-in-progress&ticker=MNKD&period=max&api_key=YOUR_API_KEY